HomeCompareABIO vs QSR

ABIO vs QSR: Dividend Comparison 2026

ABIO yields 11.04% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABIO wins by $16.8K in total portfolio value
10 years
ABIO
ABIO
● Live price
11.04%
Share price
$28.80
Annual div
$3.18
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.5K
Annual income
$2,204.34
Full ABIO calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.76
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$387.88
Full QSR calculator →

Portfolio growth — ABIO vs QSR

📍 ABIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABIOQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABIO + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABIO pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABIO
Annual income on $10K today (after 15% tax)
$938.54/yr
After 10yr DRIP, annual income (after tax)
$1,873.69/yr
QSR
Annual income on $10K today (after 15% tax)
$289.25/yr
After 10yr DRIP, annual income (after tax)
$329.70/yr
At 15% tax rate, ABIO beats the other by $1,543.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABIO + QSR for your $10,000?

ABIO: 50%QSR: 50%
100% QSR50/50100% ABIO
Portfolio after 10yr
$33.1K
Annual income
$1,296.11/yr
Blended yield
3.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

ABIO
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.7
Piotroski
2/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.6% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABIO buys
0
QSR buys
0
No recent congressional trades found for ABIO or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABIOQSR
Forward yield11.04%3.40%
Annual dividend / share$3.18$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$41.5K$24.7K
Annual income after 10y$2,204.34$387.88
Total dividends collected$16.5K$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock
Analyst consensusBuyBuy

Year-by-year: ABIO vs QSR ($10,000, DRIP)

YearABIO PortfolioABIO Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$11,804$1,104.17$11,038$337.57+$766.00ABIO
2$13,849$1,218.11$12,156$345.43+$1.7KABIO
3$16,154$1,335.59$13,359$352.69+$2.8KABIO
4$18,740$1,455.97$14,654$359.36+$4.1KABIO
5$21,631$1,578.61$16,045$365.45+$5.6KABIO
6$24,848$1,702.89$17,539$370.97+$7.3KABIO
7$28,415$1,828.18$19,143$375.96+$9.3KABIO
8$32,358$1,953.89$20,863$380.42+$11.5KABIO
9$36,703$2,079.45$22,708$384.39+$14.0KABIO
10$41,476$2,204.34$24,685$387.88+$16.8KABIO

ABIO vs QSR: Complete Analysis 2026

ABIOStock

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.

Full ABIO Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this ABIO vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABIO vs SCHDABIO vs JEPIABIO vs OABIO vs KOABIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.